Institutional investors purchased a net $7.1 thousand shares of MDCO during the quarter ended December 2014 and now own 104.91% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
POINTSTATE CAPITAL LP Bought 1.3 Million shares of Medicines Co
FRONTIER CAPITAL MANAGEMENT CO. ... Bought 1.3 Million shares of Medicines Co
CAMBER CAPITAL MANAGEMENT LLC Bought 1.3 Million shares of Medicines Co